Why diversity in clinical trials is essential to the future of UK life sciences
Date: 26 April 2023
Becoming a world leader in equality, diversity and inclusion (EDI) is essential if the UK life sciences sector wants to set itself apart from its competitors – particularly in the area of clinical trials. That is the finding of a new report from MedCity, the Faculty of Pharmaceutical Medicine and Imperial College Healthcare NHS Trust.
Read the report: https://www.medcityhq.com/2023/03/29/why-diversity-in-clinical-trials-is-essential-to-the-future-of-uk-life-sciences/